Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis

Acharya, 2009, Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy, Biomaterials, 10.1016/j.biomaterials.2009.07.008 Aggarwal, 2009, Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases, Int. J. Biochem. Cell Biol., 41, 40, 10.1016/j.biocel.2008.06.010 Aggarwal, 2005, Curcumin derived from turmeric (Curcuma longa): a spice for all seasons Aggarwal, 2003, Anticancer potential of curcumin: preclinical and clinical studies, Anticancer Res., 23, 363 Aggarwal, 2005, Curcumin suppresses the paclitaxel-induced nuclear factor-{kappa}B pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice, Clin. Cancer Res., 11, 7490, 10.1158/1078-0432.CCR-05-1192 Aggarwal, 2003, Cox-2 is needed but not sufficient for apoptosis induced by Cox-selective inhibitors in colon cancer cells, Apoptosis, 8, 649, 10.1023/A:1026199929747 Anand, 2007, Bioavailability of curcumin: problems and promises, Mol. Pharmacol., 4, 807, 10.1021/mp700113r Anand, 2008, Curcumin and Cancer: an “old-age” disease with an “age-old” solution, Cancer Lett., 267, 133, 10.1016/j.canlet.2008.03.025 Ansari, 2005, Stability indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations, J. Pharm. Biomed. Anal., 39, 132, 10.1016/j.jpba.2005.03.021 Azuine, 1992, Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice, Nutr. Cancer, 17, 77, 10.1080/01635589209514174 Bradford, 1976, Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Buttke, 1994, Oxidative stress as a mediator of apoptosis, Immunol. Today, 15, 7, 10.1016/0167-5699(94)90018-3 Chattopadhyay, 2004, Turmeric and curcumin: biological actions and medicinal applications, Curr. Sci., 87, 44 Chearwae, 2006, Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1), Cancer Chemother. Pharmacol., 57, 376, 10.1007/s00280-005-0052-1 Chearwae, 2004, Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder, Biochem. Pharmacol., 68, 2043, 10.1016/j.bcp.2004.07.009 Christine, 2004, Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2, Mol. Cancer Ther., 3, 1101, 10.1158/1535-7163.1101.3.9 DeSilva, 2003, Interactions of surfactant protein D with fatty acids, Am. J. Respir. Cell Mol. Biol., 29, 757, 10.1165/rcmb.2003-0186OC Dorai, 2001, Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo, Prostate, 47, 293, 10.1002/pros.1074 Fry, 1978, Rapid separation of low molecular weight solutes from liposomes without dilution, J. Anal. Biochem., 90, 803, 10.1016/0003-2697(78)90172-0 Ganta, 2009, Coadministration of paclitaxel and Curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells, Mol. Pharmacol., 6, 928, 10.1021/mp800240j Grabarek, 1990, Zero-length crosslinking procedure with the use of active esters, Anal. Biochem., 185, 131, 10.1016/0003-2697(90)90267-D Gupta, 2009, Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy, Int. J. Nanomed., 4, 115, 10.2147/IJN.S5581 Gupta, 2007, Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain, J. Pharm. Pharmacol., 59, 935, 10.1211/jpp.59.7.0004 Hussain, 2000, Ligand-mediated tissue specific drug delivery, Adv. Drug Deliv. Rev., 43, 95, 10.1016/S0169-409X(00)00066-1 Jacobson, 1996, Reactive oxygen species and programmed cell death, Trends Biochem. Sci., 21, 83, 10.1016/S0968-0004(96)20008-8 Jenning, 2000, Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties, J. Control. Release, 66, 115, 10.1016/S0168-3659(99)00223-0 Joe, 2004, Biological properties of curcumin-cellular and molecular mechanisms of action, Crit. Rev. Food Sci. Nutr., 44, 97, 10.1080/10408690490424702 Kunwar, 2008, Quantitative cellular uptake, localization and cytotoxicity of Curcumin in normal and tumor cells, Biochem. Biophys. Acta, 1780, 673, 10.1016/j.bbagen.2007.11.016 Lemieux, 1994, Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate, Anticancer Res., 14, 397 Lee, 2007, Preparation and characterization of bis-ethylhexyloxyphenolmethoxyphenyltriazine (BEMT) loaded solid lipid nanoparticles (SLN), J. Ind. Eng. Chem., 13, 1180 Li, 2009, In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles, Cancer Lett., 274, 319, 10.1016/j.canlet.2008.09.024 Maruyama, 2004, Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin–PEG liposomes, for boron neutron-capture therapy (BNCT), J. Control. Release, 98, 195, 10.1016/j.jconrel.2004.04.018 Mulik, 2009, Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: physicochemical characterization and stability study, Eur. J. Pharm. Sci., 37, 395, 10.1016/j.ejps.2009.03.009 Page-Clisson, 1998, Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier, J. Control Release, 56, 23, 10.1016/S0168-3659(98)00065-0 Qian, 2002, Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway, Pharmacol. Rev., 54, 561, 10.1124/pr.54.4.561 Ramachandran, 2002, Curcumin inhibits telomerase activity through human telomerase reverse transcriptase in MCF-7 breast cancer cell line, Cancer Lett., 184, 1, 10.1016/S0304-3835(02)00192-1 Sahoo, 2005, Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention, Mol. Pharmacol., 2, 373, 10.1021/mp050032z Shi, 2006, Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells, Cell Biol. Int., 30, 221, 10.1016/j.cellbi.2005.10.024 Singh, 1995, Activation of transcription factor NF-kB is suppressed by curcumin (diferulolylmethane), J. Biol. Chem., 270, 24995, 10.1074/jbc.270.42.24995 Skommer, 2006, Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines, Exp. Hematol., 34, 463, 10.1016/j.exphem.2005.12.015 Thangapazham, 2006, Multiple molecular targets in cancer chemoprevention by curcumin, AAPS J., 8, E443, 10.1208/aapsj080352 Tiyaboonchaia, 2007, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles, Int. J. Pharm., 337, 299, 10.1016/j.ijpharm.2006.12.043 Ulbrich, 2009, Transferrin and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB), Eur. J. Pharm. Biopharm., 71, 251, 10.1016/j.ejpb.2008.08.021 Vandewalle, 1985, Transferrin receptors in cultured breast cancer cells, J. Cancer Res. Clin. Oncol., 110, 71, 10.1007/BF00402505 Van, 1998, Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine externalization, Cytometry, 31, 1, 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R Wang, 2000, Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells, Anticancer Res., 20, 799 Wang, 1999, Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader, Free Radic. Biol. Med., 27, 612, 10.1016/S0891-5849(99)00107-0 Weir, 2007, Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK, Cancer Biol. Ther., 6, 178, 10.4161/cbt.6.2.3577 Widera, 2003, Mechanisms of Tfr-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery, Adv. Drug Deliv. Rev., 55, 1439, 10.1016/j.addr.2003.07.004 Yang, 2009, Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against bcl-2, Mol. Pharmacol., 6, 221, 10.1021/mp800149s